19th Jan 2015 13:29
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities (PDMR) and Connected Persons on 16 January 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1427.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.19 per ADS following the notional re-investment of the dividend paid to shareholders on 8 January 2015.
Director/PDMR | Ordinary Shares | ADSs |
Sir Andrew Witty | 18,634.726 | |
Dr M M Slaoui | 5,838.447 | |
Mr S Dingemans | 7,826.922 | |
Mr R G Connor | 2,559.691 | |
Mrs D P Connelly | 2,427.946 | |
Mr N Hirons | 314.028 | |
Mr S A Hussain | 6,349.257 | |
Mr W C Louv | 1,712.688 | |
Mr D S Redfern | 2,695.290 | |
Ms C Thomas | 3,719.918 | |
Mr P C Thomson | 1,814.523 | |
Mr D E Troy | 3,469.890 | |
Dr P J T Vallance | 7,749.851 | |
Ms E Walmsley | 4,505.102 | |
Mrs V A Whyte | 515.784 |
Connected Person |
Ordinary Shares |
ADSs |
Dr K Slaoui (connected person to Dr M M Slaoui) | 88.247 | |
Mrs K Thomson (connected person to Mr P C Thomson) | 84.998 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
19 January 2015
Related Shares:
Glaxosmithkline